Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Limited has notified BSE about its 31st Annual General Meeting scheduled for Thursday, 25 September 2025 at 3:00 PM, to be held via Video Conferencing. Shareholders will vote on ordinary items including adopting FY25 financial statements, reappointing Mr. Ramanlal Trivedi (DIN: 01658705) as Director (retiring by rotation), and reappointing M/s. Rishi Sekhri and Associates as statutory auditors for a five-year term up to the 2030 AGM. Two special resolutions seek shareholder approval to enhance the company's borrowing limit to Rs. 100 crores under Section 180(1)(c) and to authorize investments, loans, guarantees and securities up to Rs. 100 crores under Section 186 of the Companies Act. The e-voting window runs from 22 September to 24 September 2025, with the cut-off date set as 18 September 2025.
The borrowing limit hike and expanded investment authority signal that the company is preparing for potentially larger debt or investment activity, which shareholders should evaluate. Approval of these special resolutions will give the board wider financial flexibility, while reappointment of the existing director and auditor indicates continuity in leadership and oversight.